TITLE

Human papillomavirus vaccines launch a new era in cervical cancer prevention

AUTHOR(S)
Dawar, Meenakshi; Deeks, Shelley; Dobson, Simon
PUB. DATE
August 2007
SOURCE
CMAJ: Canadian Medical Association Journal;8/28/2007, Vol. 177 Issue 5, p456
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the launch of human papillomavirus (HPV) vaccine, which is being seen as a new means in cervical cancer prevention. According to research, HPV is one of the most common sexually transmitted infections in the world. In Canada, the age-adjusted prevalence of all types of HPV is 16.8%. There are more than 100 DNA viruses involved in the HPV family. Infection with a high-risk type of HPV is a known cause of cervical cancer. Vaccine trials have examined HPV infection and cancer of the cervix and other genital sites. Conclusions on research pertaining to vaccines show that both Gardasil and Cervarix are empty virus-like particle vaccines, created using recombinant technology and both are safe, providing protection against infection by HPV types 16 and 18.
ACCESSION #
26595339

 

Related Articles

  • The War on HPV. Kalb, Claudia; Springen, Karen // Newsweek (Pacific Edition);5/8/2006 (Pacific Edition), Vol. 147 Issue 19, p42 

    The article focuses on a vaccine against human papillomavirus (HPV), the sexually transmitted disease that causes cervical cancer. Cervical cancer causes about 250,000 deaths each year, largely in developing countries in which access to medical care is limited. As many as 80% of women will be...

  • The War on HPV. Kalb, Claudia; Springen, Karen // Newsweek;4/24/2006, Vol. 147 Issue 17, p61 

    The article focuses on a vaccine against human papillomavirus (HPV), the sexually transmitted disease that causes cervical cancer. Cervical cancer causes about 250,000 deaths each year, largely in developing countries in which access to medical care is limited. As many as 80% of women will be...

  • The War on HPV. Kalb, Claudia; Springen, Karen // Newsweek (Atlantic Edition);5/8/2006 (Atlantic Edition), Vol. 147 Issue 19, p44 

    The article focuses on a vaccine against human papillomavirus (HPV), the sexually transmitted disease that causes cervical cancer. Cervical cancer causes about 250,000 deaths each year, largely in developing countries in which access to medical care is limited. As many as 80% of women will be...

  • A Vaccine for Cervical Cancer: Does Your Daughter Need It? Neustaedter, Randall // Homeopathy Today;Sep/Oct2007, Vol. 27 Issue 5, p12 

    The article reports on the legislation of Human Papillomavirus (HPV) vaccine approved by the U.S. Food and Drug Administration. It cites that at least 41 states have introduced legislation to require, fund, or educate the public about HPV vaccine. Moreover, the objective of the said effort is to...

  • STDs SCARIER THAN CANCER FOR TEENAGERS.  // USA Today Magazine;Jul2013, Vol. 142 Issue 2818, p8 

    The article discusses a study which examined the use of human papillomavirus (HPV) vaccine in preventing cervical cancer and sexually transmitted diseases (STD) in women.

  • Not a Cure for Cancer, But Close. Carmichael, Mary // Newsweek;12/2/2002, Vol. 140 Issue 23, p9 

    Reports on the development of a vaccine for the sexually-transmitted disease human papillomavirus (HPV). Association between HPV and cervical cancer; Significance of this discovery; Plans of Merck to market the vaccine by 2007.

  • January is Cervical Cancer awareness month.  // Tennessee Tribune;1/20/2011, Vol. 22 Issue 3, p6B 

    The article offers information on the preventive measures for protection, symptoms, and risk factors of cervical cancer which is mostly acquired by women because of human papilloma virus infection.

  • HPV vaccination shows limited cost effectiveness in Austria.  // PharmacoEconomics & Outcomes News;9/19/2009, Issue 587, p8 

    The article discusses research which concluded the limited cost effectiveness of human papillomavirus (HPV) vaccination in the prevention of cervical cancer in Austria. It references a study by I. Zechmeister et al published in the August 13, 2009 issue of the journal "Vaccine." Three...

  • Microbicides in the Prevention of HIV Infection: Current Status and Future Directions. Nuttall, Jeremy // Drugs;2010, Vol. 70 Issue 10, p1231 

    More than 28 years since the first cases of HIV/AIDS, there is still no cure or vaccine. The worst affected region is sub-Saharan Africa and, increasingly, it is young women who are bearing the brunt of the epidemic. Consequently, there is an urgent need for HIV prevention options for women in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics